Drug Utilization Study in Respiratory Disorders in In-Patients of Medical Ward in A Tertiary Teaching Care Hospital
Authors/Creators
- 1. Senior Resident, Department of Pharmacology, GMERS Medical College Dharpur, Patan, Gujarat, India
- 2. Professor, Department of Pharmacology, Shree MP Shah Medical College Jamnagar, Gujarat, India
- 3. Assistant Professor, Department of Pharmacology, GMERS Medical College Dharpur, Patan, Gujarat, India
Description
Background: The study of prescribing pattern is a part of the medical audit and seeks to monitor, evaluate and if necessary, suggest modification in prescribing practices to make medical care rational and cost effective. Appropriate drug utilization it terms of efficacy, safety, convenience and economic aspects at all levels in the chain of drug use. Respiratory disease causes an immense worldwide health burden. In India, Asthma was one of the leading causes of morbidity and mortality in rural India. COPD is the fourth leading cause of death worldwide and the numbers are growing (CDC). Objectives: The aim of study is obtain data on the current prescribing pattern and drug utilization trend in Patients of Respiratory Disorders in a tertiary care teaching hospital with ultimate goal to promote appropriate use of drugs. Methods: The longitudinal, prospective, Observational study conducted for duration of 12 months on 620 Respiratory patients after approval from Institutional Ethics Committee. Results: Most common age group affected was 41-60 year. Majority of patients were male. Average number of drugs per encounter is 10.04, among this minimum 5 drugs prescribed and maximum 19 drugs prescribed. 72.88% drugs were prescribed by generic name. 67.79% drugs were prescribed from NLEMI 2015. 59.32% were prescribed from WHO model list of essential medicine. Majority of the drugs were given via oral route. Theophylline [29.37%] was the commonest drug prescribed. Majority of drugs were Drug acting on respiratory system followed by Anti-microbial Drug. Among the Antimicrobial Drugs, Amoxicillin was the commonest drug prescribed. Commonly used FDCs was amoxicillin + clavulanic acid 45.76%. Majority of patients had Chronic Obstructive Pulmonary Disease and Majority of patients was Tobacco Chewing. Conclusion: Despite some limitations such as single centre as well as relatively small sample size, the data generated from the present study can be used to plan multi-centric studies in the future. Drugs prescribed by generic name and drugs from WHO and National List of Essential Medicines should be promoted as it increase the rationality of prescription.
Abstract (English)
Background: The study of prescribing pattern is a part of the medical audit and seeks to monitor, evaluate and if necessary, suggest modification in prescribing practices to make medical care rational and cost effective. Appropriate drug utilization it terms of efficacy, safety, convenience and economic aspects at all levels in the chain of drug use. Respiratory disease causes an immense worldwide health burden. In India, Asthma was one of the leading causes of morbidity and mortality in rural India. COPD is the fourth leading cause of death worldwide and the numbers are growing (CDC). Objectives: The aim of study is obtain data on the current prescribing pattern and drug utilization trend in Patients of Respiratory Disorders in a tertiary care teaching hospital with ultimate goal to promote appropriate use of drugs. Methods: The longitudinal, prospective, Observational study conducted for duration of 12 months on 620 Respiratory patients after approval from Institutional Ethics Committee. Results: Most common age group affected was 41-60 year. Majority of patients were male. Average number of drugs per encounter is 10.04, among this minimum 5 drugs prescribed and maximum 19 drugs prescribed. 72.88% drugs were prescribed by generic name. 67.79% drugs were prescribed from NLEMI 2015. 59.32% were prescribed from WHO model list of essential medicine. Majority of the drugs were given via oral route. Theophylline [29.37%] was the commonest drug prescribed. Majority of drugs were Drug acting on respiratory system followed by Anti-microbial Drug. Among the Antimicrobial Drugs, Amoxicillin was the commonest drug prescribed. Commonly used FDCs was amoxicillin + clavulanic acid 45.76%. Majority of patients had Chronic Obstructive Pulmonary Disease and Majority of patients was Tobacco Chewing. Conclusion: Despite some limitations such as single centre as well as relatively small sample size, the data generated from the present study can be used to plan multi-centric studies in the future. Drugs prescribed by generic name and drugs from WHO and National List of Essential Medicines should be promoted as it increase the rationality of prescription.
Files
IJPCR,Vol15,Issue6,Article238.pdf
Files
(511.8 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:4e82b121eec74bd5fddd80e1882664cf
|
511.8 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-05-30
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue6,Article238.pdf
- Development Status
- Active
References
- 1. Lee D, Bergman U Studies of utilization In: Strom BL, editor. Pharmacoepidemiology. New York. Churchill Livingstone. 1989 259-274.2. Rehana HS, Nagarani MA, Rehan M. A study of the drug prescribing pattern and use of antimicrobial agents at a tertiary care teaching hospital in eastern Nepal. Indian J Pharmacol. 1998; 30:175-80. 3. World Health Organization. The global burden of disease: 2004 update. Geneva, WHO, 2008. Available at www. who. int/ evidence/bod. 4. Shewade DG, Pradhan SC. Auditing of prescriptions in a government teaching hospital and four retail medical stores in Pondicherry. Indian J Pharamcol 1998; 30:408-10. 5. WHO. How to investigate drug use in health facilities: selected drug use indicators. Geneva, World Health Organization. 1993. WHO / DAP 1993; 1:1-87. 6. Smith KR. National Burden of disease in India from indoor air pollution. 2000. Proc Natl Acad Sci USA. Nov 21, 97(24). 13286-93. 7. Nandimath Mk, Ahuja S. Drug Prescribing Pattern In Upper Respiratory Tract Infection In Children Aged 1–14 Years. International Journal of Pharma& Bio Sciences. 2012; 3 (1):299-308. 8. Divya Kancherla1, Satya Sai M V. A study on prescribing pattern of antibiotics in respiratory tract infections in a tertiary care center. International Journal of Recent Scientific Research. June, 2015; 6(6): 4558-4563. 9. R. D. Shimpi, P. S. Salunkhe. Drug utilization evaluation and prescription monitoring in asthmatic patients. International Journal of Pharma& Bio Sciences. JAN-MARCH, 2012; 2(1):117-122. 10. Harish Govind Naik, Chitra C Khanwelkar. Drug utilization study on antibiotics use in lower respiratory tract infection. National Journal of medical research. Oct–Dec 2013; 3(4). 11. Lakshmi R, Lavanya Chandran R. A study on antibiotic prescribing pattern in obstructive lung disease inpatients. Asian j pharm clin res. 2016; 9(1): 260-262. 12. Mona M. Ahmed, Ashraf A. ELMaraghy. Study of prescription patterns of antibiotics in treating lower respiratory tract infections at Sohag Chest Hospital. Egyptian Journal of Chest Diseases and Tuberculosis. 2016; 65: 143–155. 13. Bourbeau, RJ Sebaldt, A Day, et al. Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: The CAGE study. Can Respir J. 2008;15(1):13-19. 14. Huchon G, Gialdroni-Grassi G, Leophonte P, Manresa F, Schaberg T, Woodhead M. Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey. European Respiratory Journal. 1996; 9(8): 15905. 15. Shaji J, Lodha S. Management of asthma: A review. Indian Journal of Hospital Pharmacy. 2008; 45: 88-100. 16. Mishra N, Ro KVR, Padhi Sk. Asthma education for better compliance in disease management. Indian Journal of Allergy Asthma Immunology. 2005; 19: 25-28. 17. "Respiratory Disease & Oral Health".unitedconcordia.com. Jump up American Academy of Periodontology, kpmjkk 2008 http://www.irishscientist.ie/2004/conte nts.asp?contentxml=04p 104.xml&contentxsl=is04pages.xs . 18. Vestbo, Jørgen. Definition and Overview (PDF). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Global Initiative for Chronic Obstructive Lung Disease. 2013; 1–7. 19. Sharma, Sat. Restrictive Lung Disease. Retrieved, 2008-04-19. 20. Robert Beaglehole AI, Thomson Prentice. The World Health Report 2004 - Changing History. World Health Organization. 2004:120–4.21. 9th report of the WHO expert committee: The use of essential drugs. WHO TRS. 895, 2000. 22. World Health Organization. The global burden of disease: 2004 update. Geneva, WHO, 2008. Available at www. who. int/ evidence/bod. 23. http://foundation.thoracic.org/news/glo balburdenphp; ATS Foundation. The Global Burden of Lung Disease. 24. Aggarwal AN, Chaudhry K, Chhabra SK, D'Souza GA, Gupta D, Jindal SK, et al. Prevalence and risk factors for bronchial asthma in Indian adults: a multi-centre study. Indian J Chest Dis Allied Sci. 2006; 48:13-22. 25. Viswanathan R. Definition, incidence, aetiology and natural history of asthma. Indian J Chest Dis. 1964; 6: 108-24. 26. Chhabra SK, Gupta CK, Chhabra P, Rajpal S. Prevalence of bronchial asthma in schoolchildren in Delhi. J Asthma. 1998; 35:291-6. 27. Jindal SK, Aggarwal AN, Gupta D, Agarwal R, Kumar R, Kaur T, et al. Indian study on epidemiology of asthma, respiratory symptoms and chronic bronchitis in adults (INSEARCH). Int J Tuberc Lung Dis 2012; 16:1270-7.